Recombinant Zebrafish ARHGAP17B

• Cat.No.: ARHGAP17B-6493Z
• Product Overview: Recombinant Zebrafish ARHGAP17B full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Zebrafish
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 oC for short term. For long term storage, store it at -20 oC～-80 oC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: arhgap17b Rho GTPase activating protein 17b [ Danio rerio (zebrafish) ]
• Official Symbol: ARHGAP17B
• Gene ID: 100141341
• mRNA Refseq: NM_001114906
• Protein Refseq: NP_001108378
• UniProt ID: A8WG50

Reviews

08/17/2022

The combination of high-quality ARHGAP17B protein and excellent technical support provided by the manufacturer makes them the ideal choice for my research.

01/23/2022

The ARHGAP17B protein offered by the manufacturer is of exceptional quality, and it meets the rigorous standards necessary for my experimental needs.

09/22/2021

Their commitment to delivering exceptional products and assisting with any challenges that may arise ensures a successful and rewarding experimental journey.

07/05/2021

The protein bands detected were exceptionally distinct, enabling easy interpretation and accurate analysis of protein expression patterns.

03/12/2021

The manufacturer's commitment to providing excellent technical support is highly valuable.

03/01/2020

Its ability to preserve structural integrity and facilitate high-resolution imaging has greatly enhanced my understanding of protein complexes and their interactions.

10/03/2016

Furthermore, the ARHGAP17B protein has demonstrated great utility in protein electron microscopy structure analysis.

05/05/2016

The ARHGAP17B protein's reliability and ease of use have made it an essential component of my structural investigations.

Q&As

How is ARHGAP17B expression regulated?

The regulation of ARHGAP17B expression is not well-studied. However, it is known that various signaling pathways and transcription factors can influence the expression of Rho GTPases and their regulators. Further research is needed to understand the specific regulatory mechanisms of ARHGAP17B.

Does ARHGAP17B have any roles in cancer progression or development?

The potential involvement of ARHGAP17B in cancer progression or development is not extensively studied. However, dysregulation of Rho GTPases and their regulators is associated with various aspects of cancer, such as cell migration, invasion, and metastasis. Therefore, it is possible that ARHGAP17B may contribute to these processes in cancer. Further investigation is needed to understand its specific role in cancer biology.

Is there any evidence linking ARHGAP17B to neurodegenerative diseases?

Currently, there is no direct evidence linking ARHGAP17B to neurodegenerative diseases. However, since ARHGAP17B is expressed in the brain and involved in cytoskeletal dynamics, it is plausible that it could play a role in neurodegenerative processes. Further research is required to explore any potential associations between ARHGAP17B and neurodegenerative diseases.

Can ARHGAP17B be targeted for therapeutic purposes?

As of now, there is limited research on the therapeutic potential of targeting ARHGAP17B. However, since it is involved in cytoskeletal regulation and cell migration processes, it may be a potential target for diseases characterized by abnormal cell migration, such as cancer metastasis. Further research is needed to explore the therapeutic possibilities of ARHGAP17B.

Are there any isoforms or homologs of ARHGAP17B?

Currently, there are no known isoforms or closely related homologs of ARHGAP17B. It appears to be a unique protein in terms of its sequence and function.

Are there any known genetic mutations or variants associated with ARHGAP17B?

To the best of our knowledge, there are no reported genetic mutations or variants specifically associated with ARHGAP17B. However, genetic variations in other genes within the Rho GTPase signaling pathway or related genes could indirectly impact the function or regulation of ARHGAP17B.

Can ARHGAP17B interact with other proteins or molecules?

There is limited information on the specific protein-protein interactions involving ARHGAP17B. However, being a GAP for RhoA and CDC42, it is likely to interact with these GTPases. Additionally, ARHGAP17B may potentially interact with other proteins involved in the Rho GTPase signaling pathway or related cellular processes. Further research is required to elucidate the specific protein interactions of ARHGAP17B.

Are there any post-translational modifications known for ARHGAP17B?

Little is known about the post-translational modifications of ARHGAP17B. However, since many proteins undergo modifications such as phosphorylation or ubiquitination, it is plausible that ARHGAP17B may also be subject to such modifications. More research is necessary to determine the extent of post-translational modifications on ARHGAP17B.

What cellular processes or pathways are influenced by ARHGAP17B?

ARHGAP17B plays a role in various cellular processes and pathways. It regulates cytoskeletal dynamics, cell adhesion, and cell migration by modulating the activity of RhoA and CDC42, which are key regulators of the actin cytoskeleton. ARHGAP17B's function in these processes influences cell shape, motility, and intercellular interactions.